BiondVax Pharmaceuticals (NASDAQ:BVXV) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report issued on Monday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance BiondVax Pharmaceuticals has a fifty-two week low of $1.25 and a fifty-two week high of $11.80. The stock has a 50-day simple moving […]